Illumina Forms New Company to Enable Early Cancer Detection via Blood-Based Screening
Illumina Forms New Company to Enable Early Cancer Detection via Blood-Based Screening
Illumina Forms New Company to Enable Early Cancer Detection via Blood-Based Screening
Lonza and Renova Therapeutics Announce Manufacturing Agreement for Clinical Supply of RT-100 Gene Therapy
Multi-phase collaboration to advance next-generation sequencing, single-cell biology, and bioinformatics Sample to Insight solutions
Roche Presents Updated Results for Investigational Cancer Immunotherapy Atezolizumab in Advanced Bladder Cancer
Alliance Combines the Power of Precise Single-Cell Isolation with Next Generation Sequencing
PCRmax to Launch Updated Alpha Cycler 4 Software at Arab Lab, 2016
Sir Ranulph Fiennes attends launch event at the Source BioScience facility in Rochdale
Dako, an Agilent Technologies Company, Announces Expanded FDA Approval of Complementary Diagnostic Test to Include Melanoma
Siemens Healthcare’s Multitom Rax Heralds New Era in Diagnostic Imaging, Says GlobalData Analyst
Protagen Supports Novel Route to Serum Based Prostate Cancer Diagnostics
SelectScience® spoke to a scientist and entrepreneur who believes the secret to love lies in our genes
The SelectScience article library contains downloads on the very latest technologies being used in cancer research and diagnostics
Latest update of industry manual for development of high-throughput screening assays calls on scientists from leading 3D cell culture provider for standardized viability, toxicity protocols.
Combines accuracy with affordability to deliver rapid count results
FDA centers and researchers gain access to QIAGEN’s enhanced solutions for applications including microbial and microbiome analysis
Agena Bioscience Partners with DaRui Biotech to Bring MassARRAY Technology to the Diagnostics Market in China
SEAL Analytical Focuses On Reliable High-Throughput Analysis
The New Shimadzu Application Hand¬book “Clinical”